Sponsorship Inquiries
Event Resources

Home
Honorees
Sponsors
Travel & Pricing
Gallery
Watch Now

Mallinckrodt Pharmaceuticals for Terlivaz®

Post by sroberts in on April 27, 2023

« CSL Behring and uniQure for Hemgenix®

Marinus Pharmaceuticals for Ztalmy® »

We're social

Tweets by RareDiseases

About NORD

With a 40-year history of advancing care, treatments and policy, the National Organization for Rare Disorders (NORD) is the leading and longest-standing patient advocacy group for the more than 30 million Americans living with a rare disease. NORD, a 501(c)(3) nonprofit, is dedicated to individuals with rare diseases and the organizations that serve them. NORD, along with its more than 340 patient organization members, is committed to improving the health and well-being of people with rare diseases by driving advances in care, research and policy. Facts about the impact of rare diseases in the U.S. can be found here. For more information, please visit rarediseases.org.

© NORD. NORD, Rare Impact Awards are registered trademarks of The National Organization for Rare Disorders. | All Rights Reserved.

Home
Honorees
Sponsors
Travel & Pricing
Gallery
Watch Now

Sponsorship Inquiries
Event Resources